| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,751 |
|
|
| Direct
Value |
$1,289,193 |
|
|
|
Indirect Value
|
$541,649,045 |
|
|
| Total
Shares |
57,492,936 |
|
|
| Total
Value |
$542,938,238 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
58
|
50
|
|
Stock
price went up :
|
44
|
16
|
| Stock
price went down : |
14
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
3.1
|
3.1
|
| Percentage
Gain/Loss : |
 17.3%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-01-08 |
25,900 |
2024-01-08 |
10,768,430 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
610 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 25
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2006-05-12 |
4 |
A |
$1.67 |
$166,570 |
I/I |
100,000 |
2,818,360 |
|
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2006-05-15 |
4 |
A |
$1.51 |
$203,405 |
I/I |
135,000 |
2,953,360 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2007-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
1,918,170 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2007-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
1,918,170 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-07 |
4/A |
A |
$0.00 |
$0 |
D/D |
22,759 |
1,783,564 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-07 |
4/A |
A |
$0.00 |
$0 |
I/I |
0 |
1,783,564 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,446 |
1,796,010 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-02-06 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
1,796,010 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
2,931,153 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100,000 |
2,931,153 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,183 |
4,183 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2014-10-08 |
4 |
A |
$3.12 |
$12,606,432 |
D/D |
4,040,523 |
17,832,785 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2014-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
17,832,785 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
See Remarks Section |
– – – |
2015-02-10 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
641,025 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
See Remarks Section |
– – – |
2015-02-10 |
4 |
A |
$3.90 |
$2,499,998 |
D/D |
641,025 |
641,025 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2015-09-14 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
20,264,396 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2015-09-14 |
4 |
A |
$3.29 |
$8,000,000 |
D/D |
2,431,611 |
20,264,396 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2015-10-02 |
4 |
A |
$3.19 |
$5,104,000 |
D/D |
1,600,000 |
21,864,396 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2015-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
21,864,396 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,757,430 |
33,728,991 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
33,728,991 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
33,980,826 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-04-16 |
4 |
A |
$1.32 |
$332,397 |
D/D |
251,835 |
33,980,826 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-01-23 |
4 |
AS |
$0.00 |
$0 |
I/I |
(0) |
2,776,660 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-01-23 |
4 |
AS |
$65.00 |
$1,300,000 |
D/D |
(20,000) |
2,776,660 |
0 |
- |
|
610 Records found
|
|
Page 1 of 25 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
